{
    "clinical_study": {
        "@rank": "58632", 
        "arm_group": [
            {
                "arm_group_label": "Etafilcon A", 
                "arm_group_type": "Active Comparator", 
                "description": "Etafilcon A"
            }, 
            {
                "arm_group_label": "Stenfilcon A", 
                "arm_group_type": "Experimental", 
                "description": "Stenfilcon A"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluation of two contact lenses"
        }, 
        "brief_title": "Evaluation of Stenfilcon A Versus Etafilcon A", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Patient Reported Outcomes", 
        "detailed_description": {
            "textblock": "One week dispensing, investigator-masked, randomized, contralateral study comparing the test\n      lens against the control lens. Each subject will be randomized to wear the test lens in one\n      eye and the control lens int the other eye."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  A person is eligible for inclusion in the study if he/she:\n\n               1. Is at least 17 years of age and has full legal capacity to volunteer;\n\n               2. Has read and signed an information consent letter;\n\n               3. Is willing and able to follow instructions and maintain the appointment\n                  schedule;\n\n               4. Is correctable to a visual acuity of 20/30 or better (in each eye) with their\n                  habitual correction and the assigned study lenses;\n\n               5. Has astigmatism less than or equal to -1.00D;\n\n               6. Is an adapted soft contact lens wearer;\n\n               7. Demonstrates an acceptable fit with the study lenses;\n\n               8. Has no active anterior segment disease or known ocular disease.\n\n                  Exclusion Criteria:\n\n        A person will be excluded from the study if he/she:\n\n          1. Has never worn contact lenses before;\n\n          2. Has any systemic disease affecting ocular health;\n\n          3. Is using any systemic or topical medications that will affect ocular health;\n\n          4. Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to\n             severe dry eyes) that would affect the wearing of contact lenses;\n\n          5. Has persistent, clinically significant corneal or conjunctival staining using sodium\n             fluorescein dye;\n\n          6. Has any clinically significant lid or conjunctival abnormalities, neovascularization,\n             corneal scars or corneal opacities;\n\n          7. Is aphakic;\n\n          8. Has undergone corneal refractive surgery;\n\n          9. Is participating in any other type of clinical or research study;\n\n         10. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "17 Years"
        }, 
        "enrollment": {
            "#text": "45", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01809834", 
            "org_study_id": "CV-12-57"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Etafilcon A", 
                    "Stenfilcon A"
                ], 
                "intervention_name": "Etafilcon A; Stenfilcon A", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Etafilcon A", 
                    "Stenfilcon A"
                ], 
                "intervention_name": "Stenfilcon A; Etafilcon A", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Waterloo", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "N2L 3G1"
                }, 
                "name": "Center for Contact Lens Research, University of Waterloo"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of Stenfilcon A Versus Etafilcon A", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Visual Analog Scale", 
            "safety_issue": "No", 
            "time_frame": "1 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01809834"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Coopervision, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Coopervision, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}